L Beccaria

Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.

Rodger A. Liddle, B. J. Gertz, S Kanayama et al. · Journal of Clinical Investigation · 1989 · 156 citations · Full text

Molecular Pharmacology, Novel Cholecystokinin, Biliary Tract +11

Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist

Owen M. Wolkowitz, Barry J. Gertz, Herbert Weingartner et al. · Biological Psychiatry · 1990 · 69 citations

Obesity, Appetite, Metabolic Syndrome +8

Reduced postprandial cholecystokinin (CCK) secretion in patients with noninsulin-dependent diabetes mellitus: evidence for a role for CCK in regulating postprandial hyperglycemia.

R A Rushakoff, Ira D. Goldfine, L Beccaria et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 59 citations

Nutrition, Postprandial Cholecystokinin, Cck Infusion +19

Regulation of Pancreatic Endocrine Function by Cholecystokinin: Studies with MK-329, a Nonpeptide Cholecystokinin Receptor Antagonist*

Rodger A. Liddle, Barry J. Gertz, Shuji Kanayama et al. · The Journal of Clinical Endocrinology & Metabolism · 1990 · 47 citations

Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease

Margherita Fabbri, Maurizio Zibetti, L Beccaria et al. · European Journal of Neurology · 2018 · 31 citations · Full text